Cantor Fitzgerald Reiterates Overweight on Prothena Corp, Maintains $129 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Prothena Corp (NASDAQ:PRTA) and maintained a price target of $129.
October 23, 2023 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on Prothena Corp and maintained a price target of $129.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Prothena Corp. The maintained price target of $129 suggests that the analyst believes the stock has potential for significant upside. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100